Patents
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
04/2006
04/19/2006EP0885215B1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
04/12/2006EP1644370A2 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
04/12/2006EP1644335A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators
04/12/2006EP1644325A2 Methods and compositions for treating amyloid-related diseases
04/12/2006EP1005356B1 Novel antibacterial agents
04/12/2006EP0903337B1 Process for the preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives
04/12/2006CN1759108A Biphenyl derivatives
04/12/2006CN1250545C Quinuclidine derivatives and medicine composition containing the derivatives
04/06/2006US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
04/04/2006US7022259 include cyclic group chain structures similar to the liquid crystal to serve as the core structure, and multi-ring structures of natural alcohol with optical activity, such as alcoholates of terpenol, borneol, cinchonidine, quinine, or their derivatives; have a high helical twisting power
04/04/2006CA2198266C Novel benzimidazole derivatives
03/2006
03/30/2006WO2005112644A3 Muscarinic acetylcholine receptor antagonists
03/30/2006WO2005019211A3 Biaryl heterocyclic compounds and methods of making and using the same
03/29/2006EP1638677A2 Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides
03/29/2006EP1638560A1 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
03/29/2006CN1753891A Ccr-3 receptor antagonists
03/28/2006US7019001 Substituted benzothiazole amide derivatives
03/28/2006US7018987 Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof
03/28/2006CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
03/23/2006WO2005000250A3 Imaging agents and methods of imaging alpha 7-nicotinic cholinergic receptor
03/23/2006US20060063809 Tri-substituted heteroaryls and methods of making and using the same
03/22/2006CN1751041A 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/16/2006WO2006027628A2 Naphthalimide derivatives as antiviral agents
03/16/2006WO2005100349A3 Polycyclic pyridines as potassium ion channel modulators
03/15/2006EP1633752A1 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
03/15/2006EP1633703A2 Isotopically labeled chemically stable reagents and process for the synthesis thereof
03/15/2006EP1633349A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
03/15/2006EP1633348A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
03/15/2006EP1309589B1 Urea compounds and methods of uses
03/14/2006US7012078 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc.
03/14/2006CA2376748C Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
03/14/2006CA2180963C Novel high enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-.beta.-amino acids
03/09/2006CA2577964A1 Ligands for g-protein coupled receptors
03/08/2006EP1631569A2 Quinuclidine derivatives binding to mucarinic m3 receptors
03/07/2006US7008951 Such as asthma or chronic obstructive pulmonary disease; mixture of a corticoid such as budesonide, fluticasone propionate or mometasone furoate and 5-(1-hydroxy-2-((5,6-diethylindan-2-yl)amino)ethyl)8-hydroxy-1,2-dihydroquinolin-2-one or its salt
03/02/2006WO2006021656A2 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists
03/02/2006WO2005072132A3 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF
03/02/2006US20060047122 Process for producing optically active-3-quinuclidinols
03/02/2006CA2574454A1 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists
03/01/2006EP1628974A2 Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (tace)
02/2006
02/23/2006WO2006018609A2 Anti-inflammatory agents
02/23/2006CA2577274A1 Anti-inflammatory agents
02/22/2006EP1626967A1 Substituted pyrazoles
02/21/2006US7001914 Compounds
02/21/2006US7001900 Central nervous system disorders
02/15/2006CN1733762A Acid absorbing agent for preparing cinchona alkaloids ligand
02/08/2006CN1732154A Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
02/02/2006WO2006010452A1 Process for preparing quinuclidinium carbamate derivatives
02/02/2006WO2005092890A3 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
02/01/2006CN1239502C Macromolecule immobilized cinchonine alkaloid ligand, synthesis method and use thereof
01/2006
01/31/2006CA2208839C Quinuclidine derivatives and medicinal composition thereof
01/26/2006US20060019996 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
01/25/2006EP1618087A2 Antibacterial agents
01/19/2006WO2006005608A1 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases
01/19/2006US20060014964 Bicyclic and tricyclic amines as modulators of chemokine receptor activity
01/19/2006US20060014956 Asymmetric Michael and Aldol additions using bifunctional cinchona-alkaloid-based catalysts
01/19/2006US20060014780 Nicotinamide derivatives useful as PDE4 inhibitors
01/19/2006CA2570155A1 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases
01/18/2006EP1615889A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
01/18/2006EP1363612A4 Peptide deformylase inhibitors
01/12/2006WO2005111033A3 Novel azabicyclic aryl derivatives
01/10/2006CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists
01/05/2006DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN
01/04/2006CN1234679C Shortened synthesis of 3, 3-diaryl propylamine derivatives
01/03/2006US6982271 selective norepinephrine and serotonin reuptake inhibitor (SSNRI); antidepressant; treating cocaine addiction; "N3 bridged" tropanes
12/2005
12/29/2005WO2005123671A1 Pyrrole derivative
12/29/2005US20050288315 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1608645A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses
12/28/2005EP1608374A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
12/28/2005EP1389208B1 Substituted azabicyclic moieties for the treatment of disease (nicotinic acethylcholine receptor agonists)
12/22/2005WO2005121137A1 Asymmetric michael and aldol addition using bifunctional cinchona-alkaloid-based catalysts
12/22/2005WO2005120707A1 Clean osmium-catalyzed asymmetric dihydroxylation and aminohydroxylation of olefins in ionic liquids followed by supercritical co2 product recovery
12/22/2005US20050283006 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
12/22/2005US20050282857 e.g. 1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-oxo-2-[4-(2-piperidin-1-yl-ethyl)-piperidin-1-yl]-ethyl 4-(2-oxo-1 ,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carboxylate; calcitonin gene related peptide antagonist; migraine or cluster headaches, non-insulin-dependent diabetes
12/21/2005EP1606288A1 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
12/21/2005CN1709891A Medicinal compound, its composition and use in pharmaceutical process
12/15/2005WO2004098590A8 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/15/2005US20050277640 Pyrimidine derivatives for treatment of hyperproliferative disorders
12/14/2005CN1708493A Selected CGRP antagonists, method for production and use thereof as medicament
12/14/2005CN1231480C 1,2,3-thiadiazole carboxylic acid (thio) esters and use thereof as pest control agent or as microbicide
12/14/2005CN1231455C Continuously hydrogen adding method
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/08/2005WO2005116012A1 Pyrrolidine derivative
12/08/2005WO2004098589A8 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/08/2005US20050272763 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005US20050272739 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/08/2005CA2564668A1 Pyrrolidine derivatives
12/07/2005EP1601635A1 Process for producing optically active alcohol in the presence of rhodium, a chiral ferrocenyldiphosphine and an optically active diamine
12/07/2005EP1217001B1 Quinuclidine compounds and drugs containing the same as the active ingredient
12/07/2005CN1705664A Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
12/01/2005WO2005112644A2 Muscarinic acetylcholine receptor antagonists
12/01/2005WO2005077899A3 Amino-substituted tricyclic derivatives and methods of use
12/01/2005US20050267111 Pharmaceutical compositions and methods for use
11/2005
11/30/2005EP1599472A1 Ccr-3 receptor antagonists
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1229375C Nicotinic acetylcholine receptor inhibitor, its prepn. and application
11/29/2005US6969726 can be used as anti-proliferative agents and/or anti-infective agents that can be used without limitation as anti-inflammatory agents
11/24/2005WO2005111033A2 Novel azabicyclic aryl derivatives
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 58